Top 15 Life Science Startup Investors in Ireland (September 2026)

Portfolio highlights

• nAperte —
• FlowForma — Unlock competitive advantage with FlowForma, the #1 no code digital process automation software & business process management tool. Get a free trial now!
• Future Grass Technology —

Portfolio highlights

• NewsWhip — NewsWhip is the world's most comprehensive content discovery and analytics database. Their suite of products give customers the ability to predict which stories will be important today, and understand how to create successful content over the long term.NewsWhip serves over 500 of the world's leading publishers, brands and agencies,including: Reebok, the Washington Post, Conde Nast, Google, MasterCard, BuzzFeed, Time Inc., and more. NewsWhip Spike is their real-time, predictive content discovery dashboard — offering a one-stop view of what's important across both the web and 5 social networks. Spike is the only tool that discovers stories within 2 minutes of publishing, and predicts their spread across social.NewsWhip Analytics is a database of how audiences have engaged with stories across every social network over the long term. NewsWhip customers use Analytics to benchmark how they stack up against competitors and track engagement trends around events and seasons.
• Offr — Offr is the new way to buy and sell property, quickly and transparently.
• Metabolomic Diagnostics — Metabolomic Diagnostics is a deep-tech company specialized in the development of novel biomarker based diagnostic solutions for complex diseases. The company has developed an effective pipeline to firstly identify diagnostic biomarker panels and then translate these panels into clinical assays ready for application in the clinical laboratory.Thispipeline combines the biomarker multiplexing capabilities of Mass Spectrometry, a powerful analytical technology, with the company’s own informatics and statistics solutions to deliver diagnostic innovation. This is reflected in Metabolomic Diagnostics’ strong and versatile IP portfolio of technical innovations and biomarkers.Our VisionMetabolomic Diagnostics’ primary vision is to develop a portfolio of diagnostic solutions which can determine, early in a woman’s pregnancy,her risk of developing major complications much later in her pregnancy and thus enabling personalized care, adapted to each woman’s individual needs. Pregnancy complications like preeclampsia, gestational diabetes, preterm birth, and in-uterine growth restriction, all have the potential to severely impact on the well-being of mother and child.The company’s innovative diagnostic solutions will assist clinicians in re-imagining how these conditions are managed: our novel risk assessment tools are specifically developed in conjunction with prenatal care providers to ensure they make a difference that really matters. This in turn will enable clinicians to improve pregnancy outcomes globally.Our solutions will empower pregnant women: accurate pregnancy risk information will allow a pregnant woman, in partnership with her care provider, to determine what prenatal care is best for her pregnancy.

Portfolio highlights

• Metabolomic Diagnostics — Metabolomic Diagnostics is a deep-tech company specialized in the development of novel biomarker based diagnostic solutions for complex diseases. The company has developed an effective pipeline to firstly identify diagnostic biomarker panels and then translate these panels into clinical assays ready for application in the clinical laboratory.Thispipeline combines the biomarker multiplexing capabilities of Mass Spectrometry, a powerful analytical technology, with the company’s own informatics and statistics solutions to deliver diagnostic innovation. This is reflected in Metabolomic Diagnostics’ strong and versatile IP portfolio of technical innovations and biomarkers.Our VisionMetabolomic Diagnostics’ primary vision is to develop a portfolio of diagnostic solutions which can determine, early in a woman’s pregnancy,her risk of developing major complications much later in her pregnancy and thus enabling personalized care, adapted to each woman’s individual needs. Pregnancy complications like preeclampsia, gestational diabetes, preterm birth, and in-uterine growth restriction, all have the potential to severely impact on the well-being of mother and child.The company’s innovative diagnostic solutions will assist clinicians in re-imagining how these conditions are managed: our novel risk assessment tools are specifically developed in conjunction with prenatal care providers to ensure they make a difference that really matters. This in turn will enable clinicians to improve pregnancy outcomes globally.Our solutions will empower pregnant women: accurate pregnancy risk information will allow a pregnant woman, in partnership with her care provider, to determine what prenatal care is best for her pregnancy.

Portfolio highlights

• MixRift — MIXRIFT - game developers specialized in Mixed Reality
• unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
• Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.

Portfolio highlights

• Metabolomic Diagnostics — Metabolomic Diagnostics is a deep-tech company specialized in the development of novel biomarker based diagnostic solutions for complex diseases. The company has developed an effective pipeline to firstly identify diagnostic biomarker panels and then translate these panels into clinical assays ready for application in the clinical laboratory.Thispipeline combines the biomarker multiplexing capabilities of Mass Spectrometry, a powerful analytical technology, with the company’s own informatics and statistics solutions to deliver diagnostic innovation. This is reflected in Metabolomic Diagnostics’ strong and versatile IP portfolio of technical innovations and biomarkers.Our VisionMetabolomic Diagnostics’ primary vision is to develop a portfolio of diagnostic solutions which can determine, early in a woman’s pregnancy,her risk of developing major complications much later in her pregnancy and thus enabling personalized care, adapted to each woman’s individual needs. Pregnancy complications like preeclampsia, gestational diabetes, preterm birth, and in-uterine growth restriction, all have the potential to severely impact on the well-being of mother and child.The company’s innovative diagnostic solutions will assist clinicians in re-imagining how these conditions are managed: our novel risk assessment tools are specifically developed in conjunction with prenatal care providers to ensure they make a difference that really matters. This in turn will enable clinicians to improve pregnancy outcomes globally.Our solutions will empower pregnant women: accurate pregnancy risk information will allow a pregnant woman, in partnership with her care provider, to determine what prenatal care is best for her pregnancy.

Portfolio highlights

• Gusto — Gusto develops web-based payroll solution for small- and medium-sized businesses. It operates an online platform that provides payroll, benefits, human resources, and integration services for employers and employees in the United States.Gusto offers health benefits and workers’ compensation benefits that include medical insurance, commuterbenefits, and 401(k) contributions as well as workers’ compensation insurance plans, time tracking, and integration services, and access to employees for processing payroll from web-enabled devices such as smartphones and tablets. It also provides access to employees and contractors to browse their previous pay stubs, review their payroll forms, verify their personal details, and statistics about their pay, tax payments and federal forms filing services, and security and support services.Gusto serves startups, coffee shops, doctors, creative agencies, lawyers, and boutiques. Edward Kim, Joshua Reeves, and Tomer London founded ZenPayRoll in 2011 that became Gusto, with its headquarters in San Francisco in California with an additional office in Denver in Colorado.
• Wonder — Introducing a new kind of home dining experience. Currently available in areas of New Jersey.
• OpenEvidence — OpenEvidence uses artificial intelligence to aggregate, synthesize, and visualize clinical evidence in understandable, clinically-useful formats that can be used to make more evidenced-based decisions and improve patient outcomes.

Portfolio highlights

• Ovagen — Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics.
• Peroptyx — Peroptyx is a platform that provides managed solutions for machine learning. At Peroptyx, they have assembled and pre-screened a qualified network of data evaluators across the globe. They strategically match ideal evaluators with each product to ensure authentic experiences through consistency and appropriate real-world contexts.
• Galway Biomedical — Galway Biomedical partners with global medical device companies to bring complex braided devices from early concept through to full-scale production.

Portfolio highlights

• Zartis — Zartis provides European software engineering teams, software development outsourcing, & tech consulting you can trust. You are who you hire.
• IP Telecom — Ireland's most competitive SME & Enterprise VoIP provider. We are Ireland's leading VoIP Phone Systems Provider. Connect your business to the technology of today.
• Spotlight Oral Care — Spotlight Oral Care aims to create the best oral health products, to educate and promote oral care, empowering people to engage with true customised preventative oral care.

Portfolio highlights

• Absci — A better, faster path to new medicines. We translate ideas into drugs with an AI-powered approach to biologic drug discovery and cell line development.
• GlycoSeLect — GlycoSeLect Ltd specialises in the development and production of Recombinant Prokaryotic Lectins (RPLs).
• Comera Life Sciences — ReForm Biologics is an engineering superior biotherapeutic formulation for fragile patients. Its proprietary technology provides patented, FDA-friendly excipients for a wide range of therapeutic biologics. Using its platforms, drug companies can make life-saving medicines easier to administer, less immunogenic, more stable, and more efficient toproduce. It was founded in 2014 and is based in Woburn, Massachusetts.

Portfolio highlights

• TECLens — TECLens is creating a crosslinking technology that may accurately fix vision issues in healthy eyes as well as treat keratoconus. It provides patients with presbyopia with the ability to regain their ability to read at a distance, controls children's progressive myopia, corrects adult vision problems like hyperopia and low-order myopia, andmore.
• Prazer Therapeutics — Prazer Therapeutics assists patients suffering from intractable diseases through the use of logical and innovative drug design approaches. They willaccomplished this through the use of new and innovative drug development platforms, such as rational molecular drug design technology and next-generation protein degradation technology.
• TRIMTECH Therapeutics — Transformative treatments for CNS and inflammatory disorders by selectively destroying disease-causing protein aggregates

Portfolio highlights

• Oceanloop — Oceanloop uses cutting-edge aquaculture technologies to transform the worldwide shrimp industry. Land-based Oceanloop shrimp farms provide high-quality, antibiotic-free, and sustainable saltwater shrimp production where consumption occurs. When compared to conventional farms, Oceanloop considerably reduces its resource utilization and environmentalfootprint.
• Wandercraft — Self- balancing and hands free movement with the innovative self-balancing feature, Atalante allows for multi-tasking and cognitive involvement as part of treatments.
• Santander Brasil — Banco Santander in Brazil, its largest division in Latin America and one of the world's most important, accounting for 50%.

Portfolio highlights

• equal1 — Equal1 Quantum System-on-a-Chip (QSoC) integrates all essential quantum computer elements onto a single chip, powering our scalable, datacenter-ready quantum servers.
• Manna Air Delivery — Drone delivery made simple
• CameraMatics — Digitize fleet management to optimize performance. Onboard sensors, smart cameras, & apps to mitigate risk, manage safety & achieve sustainability goals.

Portfolio highlights

• Pure Ocean Algae — Pure Ocean Algae is a biotechnology company that integrates value chains from macro-algae and other marine resources. The company has over the winter of 2019/20 deployed its first trial lines of Palmaria palmata to sea, with initial results being extremely positive. It has also taken primary research in tank-based vegetative production andsucceeded in developing a pilot commercial plant that can produce commercial volumes of Palmaria palmata, at levels approaching 100% per week.

Portfolio highlights

• Proba — Unlock the value of your climate actions with Proba. Transform your efforts into tradable carbon certificates, connect with partners, and create new revenue streams for your business. Schedule a call now.
• Produzindo Certo — Produzindo Certo focuses on providing solutions in the farming industry. The company offers a digital platform that automates agricultural processes, aiming to enhance efficiency and sustainability. It engages in projects that promote responsible farming practices, including carbon management and sustainable soybean production. The companycollaborates with ranchers and other stakeholders to implement pilot projects that transform social and environmental practices in agriculture.
• Ascribe Bioscience — Ascribe develops natural crop protection products that help farmers reduce disease and increase yield without harming the environment or human health.

Portfolio highlights

• Happy Health — Happy Ring is the most advanced biometric platform ever - capturing clinical grade, real-world data for research and enabling real-time.
• Synchron — The endovascular brain computer interface.
• Parabilis Medicines — Parabilis Medicines is a biopharmaceutical company in the clinical stage that focuses on developing exceptional medications targeting challenging protein structures previously deemed undruggable. Utilizing more than ten years of exclusive data, innovative laboratory techniques, and algorithms based on AI and physics, the company has introduced anovel category of stabilized, cell-penetrating alpha-helical peptides known as Helicons™. These peptides can modulate intracellular proteins that traditional drug modalities cannot reach.